Open AccessS294: LONG‐TERM SAFETY AND EFFICACY OF CAPLACIZUMAB FOR ACQUIRED THROMBOTIC THROMBOCYTOPENIC PURPURA (ATTP): THE POST‐HERCULES STUDY
Author(s) -
Scully M.,
Rubia J.,
Pavenski K.,
Metjian A.,
Knöbl P.,
Peyvandi F.,
Cataland S.,
Coppo P.,
Kremer Hovinga J. A.,
De Passos Sousa R.,
Callewaert F.,
Gunawardena S.,
Lin J.
Publication year - 2022
Publication title -
hemasphere
Language(s) - English
Resource type - Journals
SCImago Journal Rank - 0.677
H-Index - 11
ISSN - 2572-9241
DOI - 10.1097/01.hs9.0000844068.17291.63
Subject(s) - medicine , population , adverse effect , incidence (geometry) , placebo , clinical trial , thrombotic thrombocytopenic purpura , surgery , platelet , pathology , physics , alternative medicine , environmental health , optics